1. 2022
  2. Empagliflozin reduces oxidative stress through inhibition of the novel inflammation/NHE/[Na+]c/ROS-pathway in human endothelial cells

    Uthman, L., Li, X., Baartscheer, A., Schumacher, C. A., Baumgart, P., Hermanides, J., Preckel, B., Hollmann, M. W., Coronel, R., Zuurbier, C. J. & Weber, N. C., Feb 2022, In: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 146, 112515.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. 2021
  4. Sodium-glucose co-transporter 2 inhibitor empagliflozin inhibits the cardiac Na+/H+ exchanger 1: persistent inhibition under various experimental conditions

    Zuurbier, C. J., Baartscheer, A., Schumacher, C. A., Fiolet, J. W. T. & Coronel, R., 17 Dec 2021, In: Cardiovascular research. 117, 14, p. 2699-2701 3 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. Chronically elevated branched chain amino acid levels are pro-arrhythmic

    Portero, V., Nicol, T., Podliesna, S., Marchal, G. A., Baartscheer, A., Casini, S., Tadros, R., Treur, J. L., Tanck, M. W. T., Cox, I. J., Probert, F., Hough, T. A., Falcone, S., Beekman, L., Müller-Nurasyid, M., Kastenmüller, G., Gieger, C., Peters, A., Kääb, S., Sinner, M. F., & 5 othersBlease, A., Verkerk, A. O., Bezzina, C. R., Potter, P. K. & Remme, C. A., 17 Jun 2021, (E-pub ahead of print) In: Cardiovascular research.

    Research output: Contribution to journalArticleAcademicpeer-review

  6. 2020
  7. Functional modulation of atrio-ventricular conduction by enhanced late sodium current and calcium-dependent mechanisms in Scn5a1798insD/+ mice

    Rivaud, M. R., Marchal, G. A., Wolswinkel, R., Jansen, J. A., van der Made, I., Beekman, L., Ruiz-Villalba, A., Baartscheer, A., Rajamani, S., Belardinelli, L., van Veen, T. A. B., Basso, C., Thiene, G., Creemers, E. E., Bezzina, C. R. & Remme, C. A., 1 Oct 2020, In: EP Europace. 22, 10, p. 1579-1589 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  8. 2019
  9. Delayed ischaemic contracture onset by empagliflozin associates with NHE1 inhibition and is dependent on insulin in isolated mouse hearts

    Uthman, L., Nederlof, R., Eerbeek, O., Baartscheer, A., Schumacher, C., Buchholtz, N., Hollmann, M. W., Coronel, R., Weber, N. C. & Zuurbier, C. J., 1 Aug 2019, In: Cardiovascular research. 115, 10, p. 1533-1545 13 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  10. 2018
  11. Direct Cardiac Actions of Sodium Glucose Cotransporter 2 Inhibitors Target Pathogenic Mechanisms Underlying Heart Failure in Diabetic Patients

    Uthman, L., Baartscheer, A., Schumacher, C. A., Fiolet, J. W. T., Kuschma, M. C., Hollmann, M. W., Coronel, R., Weber, N. C. & Zuurbier, C. J., 21 Nov 2018, In: Frontiers in physiology. 9, 1575.

    Research output: Contribution to journalReview articleAcademicpeer-review

  12. Enhanced late sodium current underlies pro-arrhythmic intracellular sodium and calcium dysregulation in murine sodium channelopathy

    Rivaud, M. R., Baartscheer, A., Verkerk, A. O., Beekman, L., Rajamani, S., Belardinelli, L., Bezzina, C. R. & Remme, C. A., 2018, In: International journal of cardiology. 263, p. 54-62

    Research output: Contribution to journalArticleAcademicpeer-review

  13. Is IGF-1 a useful inhibitor of Na+/H+-exchanger activity?

    Baartscheer, A. & Veldkamp, M. W., 2018, In: Acta physiologica (Oxford, England). 224, 2, e13164.

    Research output: Contribution to journalEditorialAcademicpeer-review

Previous 1 2 3 4 5 6 7 Next

ID: 115913